Health
Inflammasome Therapeutics Says Study of Approximately 130000 People Reported in Nature Communications Points to Potential for Treatment or Prevention of Diabetes and Other Inflammasome-Mediated Diseases with Company’s Drugs – Business Wire
Inflammasome Therapeutics says study in Nature Communications points to potential treatment or prevention of diabetes with company’s drugs
NEWTON, Mass.–(BUSINESS WIRE)–Inflammasome Therapeutics (http://www.inflam.com), a privately held company developing therapies for prevalent, degenerative diseases, reported that data analyses published today in Nature Communications https://www.nature.com/articles/s41467-020-18528-z showed that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used to treat HIV for more than 30 years, reduced their risk of developing type 2 diabetes by 33%, a highly statistically sign…
-
Noosa News10 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News8 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business10 hours agoSolid superannuation gains continue to roll in
-
General16 hours agoAustralian super funds in showdown for Israel war crimes investments as member meetings loom